Serial prostate biopsies before and during treatment showed apoptosis of tumor cells and an increase in tumor-infiltrating CD8+ T-cells, as well as an increase in prostate specific CD8+ T-cells in the peripheral blood (116). The gene discussed is CD8A; the disease is neoplasm.